Ravendra Garg

1.2k citations

44 papers · 985 indexed · h-index 20

Impact in

Epidemiology top 5%
- Trypanosoma species research and implications
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
Parasitology top 5%

Papers in

Epidemiology 30
- Respiratory viral infections research 17
- Trypanosoma species research and implications 10
- Pneumonia and Respiratory Infections 9
Immunology 10
- Immune Cell Function and Interaction 3

Co-authors: Sylvia van Drunen Littel‐van den Hurk Anuradha Dube Volker Gerdts Andrew Potter L. Latimer Michel J. Tremblay Shyam Sundar S. Naik
Journals: Vaccine (12 papers)Antiviral Research (4 papers)Journal of General Virology (2 papers)Clinical & Experimental Immunology (2 papers)Expert Review of Vaccines (2 papers)
Partner nations: Canada India United States

In The Last Decade

Ravendra Garg

43 papers receiving 964 citations

Peers

Countries citing papers authored by Ravendra Garg

Since Specialization

Citations

This map shows the geographic impact of Ravendra Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravendra Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravendra Garg more than expected).

Fields of papers citing papers by Ravendra Garg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravendra Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravendra Garg. The network helps show where Ravendra Garg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ravendra Garg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ravendra Garg Line = papers co-authored together Ravendra Garg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection Access Microbiology ·Yamatani Hideki, Ravendra Garg, Andrea Kroeker, Volker Gerdts, Darryl Falzarano, Qiang Liu, 正行村上	2025	1
2	Mitigating effects of sublethal and lethal whole-body gamma irradiation in a mouse model with soluble melanin Journal of Radiological Protection ·Mackenzie E. Malo, Muhammad Abubakar Yamin, R Stephanie, 杨富裕, А. Е. Донцов, Ravendra Garg, Ekaterina Dadachova	2022	11
3	225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models Cancer Medicine ·Ravendra Garg, Kevin J. Allen, Wojciech Dawicki, 岩手大学地域防災研究センター, Dale L. Ludwig, Ekaterina Dadachova	2020	36
4	Innate immune protection from pneumonia virus of mice induced by a novel immunomodulator is prolonged by dual treatment and mediated by macrophages Antiviral Research ·Elisa C. Martinez, Ravendra Garg, Sylvia van Drunen Littel‐van den Hurk	2019	6
5	Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs Antiviral Research ·Ravendra Garg, L. Latimer, Susantha Gomis, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2018	5
6	A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3 Antiviral Research ·Ravendra Garg, Robert Brownlie, L. Latimer, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2018	10
7	Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity Vaccine ·Ravendra Garg, Robert Brownlie, L. Latimer, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2017	7
8	A novel combination adjuvant platform for human and animal vaccines Vaccine ·Ravendra Garg, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk, Volker Gerdts	2017	33
9	Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle Vaccine ·Sams M. A. Sadat, Masaki Oomagari, Ravendra Garg, Robert Brownlie, Sylvia van Drunen Littel‐van den Hurk	2017	15
10	A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus Virology ·Ravendra Garg, Pedro Antonio González Rojas, Elisa C. Martinez, Sylvia van Drunen Littel‐van den Hurk	2016	16
11	Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice Antiviral Research ·Elisa C. Martinez, Ravendra Garg, Pratima Shrivastava, Susantha Gomis, Sylvia van Drunen Littel‐van den Hurk	2016	8
12	Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs Vaccine ·Ravendra Garg, L. Latimer, Y. Wang, Elemir Simko, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2015	26
13	The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies Vaccine ·Ravendra Garg, L. Latimer, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2015	24
14	The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle Vaccine ·Masaki Oomagari, Ravendra Garg, Robert Brownlie, J V van den Hurk, Sylvia van Drunen Littel‐van den Hurk	2014	23
15	Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles Vaccine ·Srinivas Garlapati, Ravendra Garg, Robert Brownlie, L. Latimer, Elemir Simko, Robert E. W. Hancock, Lorne A. Babiuk, Volker Gerdts, Andrew Potter, Sylvia van Drunen Littel‐van den Hurk	2012	61
16	The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development Expert Review of Vaccines ·Ravendra Garg, Pratima Shrivastava, Sylvia van Drunen Littel‐van den Hurk	2012	25
17	Intracellular Survival ofLeishmaniaSpecies That Cause Visceral Leishmaniasis Is Significantly Reduced by HIV‐1 Protease Inhibitors The Journal of Infectious Diseases ·Xin Wang, Ravendra Garg, Nadine Messier, Shyam Sundar, Marc Ouellette, Michel J. Tremblay	2008	54
18	Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells Trends in Parasitology ·Ravendra Garg, Xin Wang, Michel J. Tremblay	2007	14
19	Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis Vaccine ·Ravendra Garg, Janmejai Kumar Srivastava, Abhijit Pal, S. Naik, Anuradha Dube	2004	16
20	Intake of nutrient supplements affects multiplication ofLeishmania donovaniin hamsters Parasitology ·Ravendra Garg, Nirpendra Singh, Anuradha Dube	2004	20

About Ravendra Garg

Ravendra Garg is a scholar working on Epidemiology, Immunology, Parasitology, Public Health, Environmental and Occupational Health and Biological Psychiatry, having authored 44 papers that have together received 985 indexed citations. Recurring topics across this work include Respiratory viral infections research (17 papers), Research on Leishmaniasis Studies (13 papers), Neonatal Respiratory Health Research (11 papers), Trypanosoma species research and implications (10 papers), Pneumonia and Respiratory Infections (9 papers), Viral gastroenteritis research and epidemiology (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Epidemiology (522 citations), Parasitology (90 citations), Immunology (280 citations), Public Health, Environmental and Occupational Health (370 citations) and Infectious Diseases (197 citations). Ravendra Garg has collaborated with scholars based in Canada, India and United States. Frequent co-authors include Sylvia van Drunen Littel‐van den Hurk, Anuradha Dube, Volker Gerdts, Andrew Potter, L. Latimer, Michel J. Tremblay, Shyam Sundar, S. Naik, Robert Brownlie and Elemir Simko. Their work appears in journals such as Vaccine, Antiviral Research, Journal of General Virology, Clinical & Experimental Immunology and Expert Review of Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact